RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
Stage 4 Non-Small Cell Lung Cancer. Stage IV non-small cell lung cancer (NSCLC) is the most advanced form of the disease. In stage IV, the cancer has metastasized, or spread, beyond the lungs into other areas of the body.About 40 percent of NSCLC patients are diagnosed with lung cancer when they are in stage IV.The five-year survival rate for those diagnosed with stage IV lung cancer is less than 10 percent.n stage IV, the cancer has metastasized, or spread, beyond the lungs into other areas of the body. About 40 percent of NSCLC patients are diagnosed with lung cancer when they are in stage IV.